When does postpartum hair loss stop?
Why buy: Formulated with one per cent Selenium DS, this shampoo is recommended for those dealing with dandruff or flaking. Not only does this antifungal active ingredient treat dandruff, but it also helps rebalance sebum composition to help reduce oiliness over time. It also helps the scalp regain its health, which is essential postpartum.
Article content
Article content
Why buy: An anti-hair loss shampoo that fortifies and protects both the hair and scalp. It also strengthens, nourishes and repairs any damage or breakage from root to tip. This leaves hair looking stronger and the scalp feeling healthier and hydrated.
Article content
Article content
Why buy: Designed to strengthen, repair and hydrate hair, this mask is suitable for all hair types and is especially great for those with medium to thick hair. Formulated with mango butter, banana, coconut cream, shea butter, sugarcane and coconut water, it provides weightless hydration that also adds shine and smooths frizz.
Article content
Article content
Why buy: This anti-hair fall scalp and hair oil creates a protective moisture barrier on the scalp and supports the skin's natural ceramide production. This not only improves the hair's appearance, but also results in four times less breakage for overall healthier hair and a moisturized scalp.
Article content
Article content
Why buy: It can be difficult navigating hair styling when experiencing postpartum hair loss. The Slick Stick can be super helpful when styling to hold hair where you want (even if it is to cover up any sparse areas). It also has a 72-hour humidity shield that helps prevent flyaways.
Article content
Why buy: Good for flaky, dry, oily scalps or scalp build up, this pre-wash oil is an easy and quick treatment that can help clarify and soothe the scalp, while also adding strength to strands. Strength that ultimately leads to less hair fall and breakage.
Article content
Article content
Article content
Why buy: Dermatologist developed, this hair serum is safe for the most sensitive skin including eczema and acne-prone skin. It helps the hair look smoother, healthier and shinier while it also nourishes, strengthens and provides protection against UV rays, pollution and heat.
Article content
Article content
Why buy: This set has it all – a stimulating scalp massager, exfoliating shampoo and a dry shampoo. Each product plays a key role in supporting a healthy scalp and preventing buildup. The exfoliating shampoo cleanses and detoxifies diminishing any follicle congestion, buildup or flakes, the scalp massage promotes circulation and the dry shampoo absorbs excess oil and helps extend washes.
Article content
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
28 minutes ago
- Globe and Mail
Point of Care Diagnostics Market to Hit USD 22.63 Billion by 2029 with 8.5% CAGR
"The major players operating in this market are Abbott (US), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Danaher (US), QuidelOrtho Corporation (US), BD (US), Thermo Fisher Scientific Inc. (US), bioMérieux (France), BIOSYNEX SA (France), EKF Diagnostics Holdings plc (UK)" Browse 786 market data Tables and 64 Figures spread through 577 Pages and in-depth TOC on "Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (TB, HAI, STD), Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx (RT-PCR, INAAT)), Sample (Blood, Urine), End User (Home Care, Hospitals) - Global Forecast to 2029 The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of 8.5%, reaching US$ 15.05 billion in 2024 and an impressive US$ 22.63 billion by 2029. The growing prevalence of chronic diseases, such as diabetes has necessitated a need for routine monitoring with early and timely detection. Since these conditions need to be constantly monitored, the demand for quick, effective, and appropriate testing methods have expanded. For instance, increasing demand for POC diagnostics like glucose monitoring products is because of the easy, quick results, which patients get, helping them to take care of the disease and make an early intervention. Government initiatives promoting POC testing, including investments in health care innovation are also contributing to increased market growth. Browse in-depth TOC on " Point of Care Diagnostics Market" 778 - Tables 59 - Figures 564 - Pages Advances such as miniaturized, transportable diagnostic devices, which present laboratory-quality findings outside of health care settings, represent a leading technological shift within the point of care diagnostics market. These small devices, largely based on new, advanced forms of biosensors, will deliver testing in real-time with higher degrees of accuracy at a faster cost and are sure to revolutionize health care. These will affect health care primarily in areas related to conditions whose management requires routine monitoring, which includes diabetes and infectious diseases. As these devices continue to become increasingly accessible and affordable, they are going to create new business opportunities in home healthcare, telemedicine, and emergency care, and accelerating adoption across all patient populations. Based on mode of purchase, the point of care diagnostics market is segmented into OTC testing products and prescription-based testing products. The prescription-based testing products segment is expected to be the fastest-growing segment in the market. Stricter regulatory standards, focus on quality, and healthcare providers' recommendation for the test are among the key factors that contribute to the high growth rate of prescription-based testing products. These products need to be subjected to very strict quality and safety measures, which improves the credibility and reliability of these products. Healthcare providers actively engage in using these tests in a way that they produce the best clinical results. With the focus on early detection, prescription-based testing continues to experience strong market growth, which is driving its high growth rate. Categorized by technology, the point of care diagnostics market is segmented into immunoassays, molecular diagnostics, and biochemistry. The biochemistry segment is the dominant technology segment because these tests can quickly, reliably, and cost-effectively provide the results for conditions such as diabetes and pregnancy & fertility testing. Real-time results offered by biochemistry-based tests, like glucose meters are easy to use and well-suited both for homecare and emergency applications. Such technologies assure on-site diagnosis without the complexity of expensive laboratory infrastructure in a point of care environment. With such convenience, accessibility, and ability to cater to increasing demands for rapid and efficient testing, biochemistry technology continues to lead the market. The key players in this market are Abbott (US), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Danaher (US), QuidelOrtho Corporation (US), BD (US), Thermo Fisher Scientific Inc. (US), bioMérieux (France), BIOSYNEX SA (France), EKF Diagnostics Holdings plc (UK), Trinity Biotech (Ireland), Werfen (US), Nova Biomedical (US), SEKISUI Diagnostics (US), and Boditech Med Inc. (South Korea). The market players have adopted various strategies such as development of advanced products, partnerships, expansions, and acquisitions to strengthen their position in the point of care diagnostics market. The organic and inorganic strategies have helped the market players expand globally by providing advanced point of care tests. Abbott is a key player in the point of care diagnostics market, offering a comprehensive range of diagnostic solutions such as blood screening, immunoassays, and clinical chemistry systems. The company's strong global presence allows it to expand its reach in both established and emerging markets. Abbott stays ahead of the competition through continuous innovation and a focus on research and development. By introducing new products and securing important regulatory approvals, Abbott has solidified its leadership. For example, in April 2024, the company's i-STAT TBI cartridge received FDA clearance to be used with whole blood, further strengthening its position in the POC diagnostics market. F. Hoffmann-La Roche Ltd is a major player in the global point of care diagnostics market, having gained a reputation as a leader in the diagnostics market. Its extensive portfolio and global presence have enabled the company to maintain its competitive edge. Roche has an excellent direct and indirect distribution network across the world, which allows it to compensate for demand volatility in the various markets. Its strategic focus both on organic and inorganic growth strategies further strengthens the company's market presence. For instance, the cobas pulse system was launched by Roche in January 2022 as a connected point-of-care solution to be used with professional blood glucose monitoring only in certain CE Mark countries. All these strategies, along with its strong presence in the market, have given Roche further opportunities to enhance its position within the point of care diagnostics market. Siemens Healthineers AG is a leading company in the point of care diagnostics market, providing a broad range of products like clinical chemistry platforms, immunodiagnostics, and molecular diagnostic testing. The company is committed to expanding its portfolio through strategic acquisitions and innovations in order to respond to the changing needs of patients and healthcare providers. Moreover, Siemens Healthineers focuses on partnerships to further strengthen its position in the market. With a significant worldwide presence in over 70 countries, the group is poised well for growth in the POC diagnostics market. For more information, Inquire Now!
CBC
3 hours ago
- CBC
Halifax dance classes for people with Parkinson's raise strength, spirits
Dance to Move offers free classes for people with Parkinson's and their caregivers. The dance classes help with mobility, balance, strength and the well-being of participants.
CBC
4 hours ago
- CBC
Get ready, Toronto: forecast calls for a sweltering weekend
Social Sharing Environment Canada has issued a heat warning for the city of Toronto this weekend. Expect daytime highs of 31 to 33 C, although it may feel closer to 40 with the humidex, the federal agency says. Overnight lows are expected around 21 to 25 C, Environment Canada says, "providing little relief from the heat." Extreme heat can bring extreme health risks. The agency is urging people to take care on Saturday and Sunday, and to check on those who live alone, more senior adults, and other people who may be at risk, including those who are pregnant. Signs of heat exhaustion include: Headache. Nausea. Dizziness. Thirst. Dark urine. Intense fatigue. If you notice them, Environment Canada says, you should stop what you're doing and drink some water. WATCH | Why cities can get extra hot, and why it's hard to cool them down: Heat is a lot worse in cities. Here's how to fix them 2 years ago Duration 4:41 With more extreme heat waves expected in the future, some communities are finding ways to become more heat resistant. In the case of heat stroke, which is more severe than heat exhaustion, Environment Canada advises people to get emergency help — including calling 911. Signs of heat stroke include: Red and hot skin. Dizziness. Nausea. Confusion. A change in consciousness levels.
